2.59% -0.014

Nexgel Inc (NXGL)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nexgel Inc Stock (NXGL) Company Profile

Healthcare (1111)

215 702-8550

2150 CABOT BLVD WEST,, LANGHORNE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NXGL's Discussions on Twitter

Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NXGL Nexgel Inc	0.526	4.93M	11.42M	-2.89M	-1.38M	-0.381
ISRG Intuitive Surgical Inc	436.64	155.16B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	147.75	40.68B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.70	33.06B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	36.16	31.30B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	207.98	30.18B	5.54B	1.52B	1.74B	10.37

Nexgel Inc Aktie (NXGL) Neueste Nachrichten

Finanzdaten der Nexgel Inc-Aktie (NXGL)

Nexgel Inc (NXGL)

Nexgel Inc Stock (NXGL) Company Profile

Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD

Nexgel Inc Aktie (NXGL) Neueste Nachrichten

Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition - MSN

NXGL Should I Buy - Intellectia AI

NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan

NXGL Stock Price, Quote & Chart | NEXGEL INC (NASDAQ:NXGL) - ChartMill

Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo

NexGel Inc stock (US65340W1027): clinical laser study puts hydrogel specialist in focus - AD HOC NEWS

Nexgel hydrogel patch reduces laser plume in hair removal study By Investing.com - Investing.com South Africa

Nexgel hydrogel patch reduces laser plume in hair removal study - Investing.com

New laser hair removal patch cuts carcinogenic plume, eases pain in study - Stock Titan

Director boosts NEXGEL (NXGL) exposure with convertible note and warrant - Stock Titan

NEXGEL (NXGL) director buys $1M convertible note and stock warrant - Stock Titan

NEXGEL (NXGL) CEO acquires convertible note and 50,000-share stock warrant - Stock Titan

NEXGEL (NXGL) director Harris Kevin McClain listed on Form 3 - Stock Titan

NEXGEL (NASDAQ: NXGL) director lists warrant and note positions - Stock Titan

NexGel Inc stock (US65340W1027): Q1 2026 numbers put hydrogel growth story in focus - AD HOC NEWS

NEXGEL, Inc. (NASDAQ:NXGL) Q1 2026 Earnings Call Transcript - Insider Monkey

Nexgel Earnings Call: BioNX Bet Amid Cash Strain - TipRanks

NexGel Raises Insider-Funded Convertible Notes to Bolster Liquidity - TipRanks

NEXGEL Adds Sequence Executives to Board After Deal Financing - MyChesCo

NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise - TradingView

NexGel (NASDAQ: NXGL) sells $1.21M in convertible notes with warrants - Stock Titan

Nexgel (NXGL) Q1 2026 Earnings Transcript - The Globe and Mail

NXGL: BioNX acquisition set to triple annual revenue and drive immediate profitability - TradingView

Earnings call transcript: Nexgel Q1 2026 reveals revenue decline, stock dips - Investing.com India

NXGL: BioNX acquisition set to triple revenue and drive profitability as legacy business stabilizes - TradingView

NexGel Q1 2026 Earnings Call Transcript - Benzinga

Nexgel Inc reports results for the quarter ended March 31Earnings Summary - TradingView

NXGL: Q1 2026 saw revenue down 5.6%, a $927K net loss, and a major acquisition funded by new capital - TradingView

NEXGEL, INC. 1Q 2026: Revenue $2.65M, EPS $(0.11) — 10-Q Summary - TradingView

NexGel (NASDAQ: NXGL) posts Q1 2026 loss and flags going concern risks amid new debt - Stock Titan

NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

NexGel Inc (NXGLW) Stock: Consolidating at $$0.05 — Next Move Ahead 2026-05-14Sector Leader - newser.com

Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical By Investing.com - Investing.com India

NEXGEL, Inc. announced that it has received $1.21 million in funding - marketscreener.com

TradingKey - TradingKey

Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical - Investing.com Australia

Nexgel appoints Dave Hazard as vice president of sales for Bionx Surgical - marketscreener.com

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical - GlobeNewswire

Nexgel Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView

NEXGEL Strengthens Board with Sequence LifeScience Leaders - TipRanks

Sequence execs join NEXGEL (NASDAQ: NXGL) board after $5.5M note deal - Stock Titan

Earnings Preview: NexGel to Report Financial Results Pre-market on May 15 - 富途牛牛

NEXGEL To Report First Quarter 2026 Financial Results on May 15th - The Manila Times

NEXGEL, Inc. to Announce First Quarter 2026 Financial Results on May 15, 2026, with Conference Call Scheduled for 12:00 P.M. ET - Quiver Quantitative

NEXGEL, Inc. announced that it expects to receive $1.21 million in funding - marketscreener.com

NEXGEL, Inc. announced that it has received $1 million in funding - marketscreener.com

NexGel (NXGL) Eps Diluted (TTM) - Zacks Investment Research

NXGLW NexGel Inc warrant holders await quarterly earnings details as report data remains unavailable, stock movement muted today.Credit Risk - newser.com

NEXGEL (NXGL) CFO details warrants, convertible note and 160,000-share option - Stock Titan

Sequence LifeScience, Inc. announced that it has received $5.5 million in funding from NEXGEL, Inc. - marketscreener.com

After $5.5M deal backing, Sequence executives take 2 NEXGEL board seats - Stock Titan

Finanzdaten der Nexgel Inc-Aktie (NXGL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NXGL